| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
E.l.f. Beauty's tariff-fueled profit hit is alerting consumer ETFs like XRT, exposing how China-sourcing risks and inflated...
The $48.7 billion Kimberly-Clark–Kenvue deal could reshape major consumer staples ETFs like XLP, VDC, and IYK.
Procter & Gamble (PG) beats expectations with strong sales and margins in Q1 2026, maintains guidance for full year.
JP Morgan analyst Andrea Teixeira maintains Procter & Gamble (NYSE:PG) with a Neutral and raises the price target from $...
- SEC Filing
Procter & Gamble rises premarket after Q1 beat, productivity gains, raised EPS guidance, steady cash returns, modest sales ...
Editor’s note: The future prices of benchmark tracking ETFs, the lede, earnings, and the latest economic releases were updated ...
Procter & Gamble (NYSE:PG) raises FY2026 Adj EPS guidance from $6.83-$7.09 to $6.83-$7.10 vs $6.97 analyst estimate. Raises...